Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Liabilities and Shareholders Equity (2019 - 2025)

Outset Medical (OM) has disclosed Liabilities and Shareholders Equity for 7 consecutive years, with $264.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 4.1% to $264.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.1 billion, a 7.95% decrease, with the full-year FY2025 number at $264.5 million, down 4.1% from a year prior.
  • Liabilities and Shareholders Equity was $264.5 million for Q4 2025 at Outset Medical, down from $277.3 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $504.8 million in Q2 2021 to a low of $264.5 million in Q4 2025.
  • A 5-year average of $355.8 million and a median of $340.3 million in 2023 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: grew 14.77% in 2021, then fell 25.18% in 2022.
  • Outset Medical's Liabilities and Shareholders Equity stood at $463.5 million in 2021, then dropped by 13.67% to $400.1 million in 2022, then fell by 21.57% to $313.8 million in 2023, then fell by 12.11% to $275.8 million in 2024, then fell by 4.1% to $264.5 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Liabilities and Shareholders Equity are $264.5 million (Q4 2025), $277.3 million (Q3 2025), and $288.8 million (Q2 2025).